Randomized, Double-Blind, Efficacy and Safety, Controlled Study, Between DMMET-01 and Metformin on Improvement of Metabolic Control in Naive Type 2 Diabetics Patients.
Phase of Trial: Phase II/III
Latest Information Update: 05 Jun 2015
At a glance
- Drugs Metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms DMMET2
- Sponsors Laboratorios Silanes
- 10 Jun 2017 Biomarkers information updated
- 20 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 May 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.